E
Syndax Pharmaceuticals, Inc. SNDX
$11.25 -$1.21-9.71%
Recommendation
Sell
Prev Close
$11.25
Volume
1,843,240
Avg Vol (90D)
2,198,470
Market Cap
$967.77M
Dividend & Yield
--
52-Week Range
$11.09 - $25.07
P/E (TTM)
--
EPS (TTM)
-$3.73
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Trexquant Investment LP Purchases 437,859 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
4/5/2025 - Ticker Report
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/4/2025 - GuruFocus
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/4/2025 - Globe Newswire
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 4.7% - Here's Why
4/4/2025 - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to Sell at StockNews.com
4/3/2025 - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 1-Year Low - Here's What Happened
4/2/2025 - MarketBeat
Syndax Pharmaceuticals Inc (SNDX) Announces Participation in Stifel 2025 Virtual Targeted ...
4/2/2025 - GuruFocus
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
4/2/2025 - Globe Newswire
Axiom Investors LLC DE Reduces Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
4/2/2025 - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 7.5% - What's Next?
4/1/2025 - MarketBeat
Syndax Pharmaceuticals (SNDX, $12.29) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 31, 2025
4/1/2025 - Tickeron - Stocks
Syndax Pharmaceuticals (SNDX, $12.29) entered Downtrend as Momentum indicator drops below 0 level on Mar 31, 2025
4/1/2025 - Tickeron - Stocks
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock Holdings Decreased by Axiom Investors LLC DE
4/1/2025 - Ticker Report
Syndax Pharmaceuticals (SNDX, $13.44) Stochastic Oscillator left the overbought zone on March 25, 2025
3/26/2025 - Tickeron - Stocks
Syndax Pharmaceuticals (SNDX, $13.73) Stochastic Oscillator left the overbought zone on March 24, 2025
3/25/2025 - Tickeron - Stocks
Syndax Pharmaceuticals (SNDX, $13.73) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 24, 2025
3/25/2025 - Tickeron - Stocks
Simplify Asset Management Inc. Buys 25,456 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
3/24/2025 - MarketBeat
Simplify Asset Management Inc. Buys 25,456 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
3/23/2025 - Ticker Report
Syndax Pharmaceuticals (SNDX, $13.71) entered Uptrend as Momentum indicator ascends above 0 level on Mar 21, 2025
3/22/2025 - Tickeron - Stocks
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 5.5% Higher on Analyst Upgrade
3/21/2025 - MarketBeat
JPMorgan Chase & Co. Increases Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $41.00
3/21/2025 - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
3/21/2025 - Ticker Report
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
3/13/2025 - MarketBeat
Syndax Pharmaceuticals (SNDX, $13) RSI Indicator left the oversold zone on March 11, 2025
3/12/2025 - Tickeron - Stocks
Syndax Pharmaceuticals (SNDX, $12.53) RSI Indicator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$23.68M
EBITDA (TTM)
-$339.66M
EBIT (TTM)
-$339.67M
Net Income (TTM)
-$318.76M
Balance Sheet
Total Assets (Q)
$724.82M
Total Debt (Q)
$345.74M
Total Liabilities (Q)
$436.69M
Book Value Per Share (Q)
$3.36
Cash Flow
Cash from Operations (TTM)
-$274.90M
Cash from Investing (TTM)
-$219.78M
Cash from Financing (TTM)
$353.37M
Net Change in Cash (TTM)
-$141.31M
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.75
7-Day Total Return
-17.04%
30-Day Total Return
-28.21%
60-Day Total Return
-18.54%
90-Day Total Return
-30.08%
Year to Date Total Return
-20.10%
1-Year Total Return
-50.85%
2-Year Total Return
-44.03%
3-Year Total Return
-42.25%
5-Year Total Return
12.61%
52-week Low
Apr 04, 2025 - $11.09
52-week High
Jul 16, 2024 - $25.07
Valuation
Market Cap
$967.77M - Small Cap
Enterprise Value
$730.60M
Price/Sales (TTM)
40.76
Price/Book (Q)
3.35
Dividends and Shares
Shares Outstanding
85.79M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.syndax.com
Phone Number
781 419 1400
Address
730 Third Avenue
New York, NY 10017
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are Revuforj, a menin inhibitor, which has... more
NASDAQ 04/04/2025 4:00PM Eastern Quotes delayed
Weiss Ratings